F | Office of Evaluation and Inspections

Family Support Act

• The Family Support Act of 1988: What Do Front Line Workers Know? What Do They Think? (OEI-05-89-01220; 7/92)
• State Implementation of the Family Support Act (OEI-05-90-00720; 1/90)

Back Top

Federal Grant Funds

• Earning Interest on Federal Grant Funds (Follow Up) (OAI-09-86-00059; 1/86)
• Earning Interest on Federal Grant Funds (OAI-09-86-00055; 8/95)

Back Top

Financial Arrangements

• Provider Relationships and the Use of Magnetic Resonance Under the Medicare Physician Fee Schedule (OEI-01-06-00261)
• Outside Activities of Senior-Level NIH Employees (OEI-01-04-00150; 08/05)
• Hospital Ownership of Physician Practices (OEI-05-98-00110; 9/99)
• Medicare Hospital Discharge Planning (OEI-02-94-00320; 12/97)
• Hospice and Nursing Home Contractual Relationships (OEI-05-95-00251; 11/97)
• Medicare Losses on Hospital Sales (OEI-03-96-00170; 6/97)
• Vulnerabilities in Medicaid Asset Verification (OEI-07-92-00882; 10/95)
• Medicaid Estate Recovery Programs (OEI-07-92-00880; 3/95)
• Limits on Beneficiary Financial Liability (Balance Billing) (OEI-02-92-00130; 4/93)
• Financial Arrangements Between Hospitals and Hospital-Based Physicians (OEI-09-89-00330) & (OEI-09-89-0331; 10/91)
• Financial Arrangements Between Physicians and Health Care Businesses: Report to Congress (OAI-12-88-01410; 4/89)
• Financial Arrangements Between Physicians and Health Care Businesses: Perspectives of Health Care Professionals (OAI-12-88-01411; 4/89)
• Financial Arrangements Between Physicians and Health Care Businesses: State Laws and Regulations (OAI-12-88-01412; 4/89)

Back Top

Financial Management

• HHS's Suspension and Debarment Program Helped Safeguard Federal Funding, But Opportunities for Improvement Exist OEI-04-19-00570
• Medicare Advantage Organizations Are Missing Opportunities To Use Ordering Provider Identifiers To Protect Program Integrity OEI-03-19-00432
• One Percent of Drugs With Medicaid Reimbursement Were Not FDA-Approved (OEI-03-17-00120)
• Open Payments Data: Review of Accuracy, Precision, and Consistency in Reporting (OEI-03-15-00220)
• Challenges Appear to Limit States' Use of Medicaid Payment Suspensions (OEI-09-14-00020)
• Medicaid: Vulnerabilities Related to Provider Enrollment and Ownership Disclosure (OEI-04-11-00590)
• Medicare: Vulnerabilities Related to Provider Enrollment and Ownership Disclosure (OEI-04-11-00591)
• CMS Has Not Performed Required Closeouts of Contracts Worth Billions (OEI-03-12-00680)
• Part B Payments for 340B Purchased Drugs (OEI-12-14-00030)
• States' Collection of Rebates for Drugs Paid Through Medicaid Managed Care Organizations Has Improved (OEI-05-14-00431)
• Questionable Billing for Medicaid Pediatric Dental Services in Louisiana (OEI-02-14-00120)
• Medicaid Drug Rebate Dispute Resolution Could Be Improved (OEI-05-11-00580)
• Offshore Outsourcing of Administrative Functions by State Medicaid Agencies (OEI-09-12-00530)
• Iowa Has Shifted Medicare Cost-Sharing for Dual Eligibles to the Federal Government (OEI-07-13-00480)
• Medicare's Currently Not Collectible Overpayments (OEI-03-11-00670)
• Surety Bonds Remain an Underutilized Tool To Protect Medicare From Supplier Overpayments (OEI-03-11-00350)
• States Collection of Medicaid Rebates for Drugs Paid Through Medicaid Managed Care Organizations (OEI-03-11-00480)
• Use of Surety Bonds to Recover Overpayments Made to Suppliers of Durable Medical Equipment, Prosthetics, Orthotics, and Supplies: Early Findings (OEI-03-11-00351)
• Institutional Conflicts of Interest at NIH Grantees (OEI-03-09-00480)
• Review of the Centers for Medicare and Medicaid Services' Medicaid Financial Management Oversight (OEI-06-04-00480)
• Risk Management at Health Centers (OEI-01-03-00050; 03/05)
• International Merchant Purchase Authorization Card Program: Review of Calendar Year 2001 Transactions (OEI-07-02-00510; 3/03)
• Health Service Brokers: A Monograph (OEI-05-89-00510 ; 10/90)
• Interstate Flow of Medicare Funds (OEI-12-89-89220)

Back Top

Financial Screening

• The Effect of Financial Screening and Distinct Part Rules on Access to Nursing Facilities (OEI-02-99-00340; 6/00)

Back Top

Food and Drug Administration (FDA)

• see also: Drugs and Drug Industry | Food Safety | Institutional Review Boards
• FDA's Risk Evaluation and Mitigation Strategies: Uncertain Effectiveness in Addressing the Opioid Crisis OEI-01-17-00510
• Ownership—But Not Physical Movement—of Selected Drugs Can Be Traced Through the Supply Chain OEI-05-17-00460
• Most Hospitals Obtain Compounded Drugs From Outsourcing Facilities, Which Must Meet FDA Quality Standards (OEI-01-17-00090)
• One Percent of Drugs With Medicaid Reimbursement Were Not FDA-Approved (OEI-03-17-00120)
• FDA Should Further Integrate Its Review of Cybersecurity Into the Premarket Review Process for Medical Devices (OEI-09-16-00220)
• Drug Supply Chain Security: Dispensers Received Most Tracing Information (OEI-05-16-00550)
• Challenges Remain in FDA's Inspections of Domestic Food Facilities (OEI-02-14-00420)
• Drug Supply Chain Security: Wholesalers Exchange Most Tracing Information (OEI-05-14-00640)
• FDA is Issuing More Postmarketing Requirements, but Challenges with Oversight Persist (OEI-01-14-00390)
• FDA Has Made Progress on Oversight and Inspections of Manufacturers of Generic Drugs (OEI-01-13-00600)
• High-Risk Compounded Sterile Preparations and Outsourcing by Hospitals That Use Them (OEI-01-13-00150)
• FDA Lacks Comprehensive Data To Determine Whether Risk Evaluation and Mitigation Strategies Improve Drug Safety (OEI-04-11-00510)
• FDA Has Made Progress on Oversight and Inspections of Manufacturers of Generic Drugs (OEI-01-13-00600)
• FDA's Clearance of Medical Devices Through the 510(k) Process (OEI-04-10-00480)
• FDA Lacks Comprehensive Data To Determine Whether Risk Evaluation and Mitigation Strategies Improve Drug Safety (OEI-04-11-00510)
• Dietary Supplements: Structure/Function Claims Fail To Meet Federal Requirements (OEI-01-11-00210)
• Dietary Supplements: Companies May Be Difficult To Locate in an Emergency (OEI-01-11-00211)
• Scientific Disagreements Regarding Medical Device Regulatory Decisions  (OEI-01-10-00470)
• Vulnerabilities in FDA's Oversight of State Food Facility Inspections (OEI-02-09-00430)
• FDA's Approval Status of Drugs Paid for by Medicaid (OEI-03-08-00500)
• Challenges to FDA's Ability To Monitor and Inspect Foreign Clinical Trials (PDF) (OEI-01-08-00510)
• Management of Information Technology Contracts at the Food and Drug Administration's Center for Drug Evaluation and Research (OEI-01-07-00450)
• The Food and Drug Administration's Oversight of Clinical Investigators' Financial Information (OEI-05-07-00730)
• The Food and Drug Administration's Generic Drug Review Process (OEI-04-07-00280)
• The Food and Drug Administration's Oversight of Clinical Trials
• The Food and Drug Administration's National Drug Code Directory (OEI-06-05-00060; 08/06)
• FDA's Monitoring of Postmarketing Study Commitments (OEI-01-04-00390; 06/06)
• Outside Activities of FDA Employees (OEI-01-04-00400; 02/06)

Back Top

Food Safety

• FDA's Risk Evaluation and Mitigation Strategies: Uncertain Effectiveness in Addressing the Opioid Crisis OEI-01-17-00510
• Ownership—But Not Physical Movement—of Selected Drugs Can Be Traced Through the Supply Chain OEI-05-17-00460
• One Percent of Drugs With Medicaid Reimbursement Were Not FDA-Approved (OEI-03-17-00120)
• Drug Supply Chain Security: Dispensers Received Most Tracing Information (OEI-05-16-00550)
• Challenges Remain in FDA's Inspections of Domestic Food Facilities (OEI-02-14-00420)
• Drug Supply Chain Security: Wholesalers Exchange Most Tracing Information (OEI-05-14-00640)
• Vulnerabilities in FDA's Oversight of State Food Facility Inspections (OEI-02-09-00430)
• FDA Inspections of Domestic Food Facilities (OEI-02-08-00080)
• FDA Food Facility Registry (OEI-02-08-00060)
• Traceability in the Food Supply Chain (OEI-02-06-00120; 03/09)
• Retail Food Safety (OEI-05-00-00540; 09/01)
• FDA Oversight of State Food Firm Inspections : A Call for Greater Accountability (OEI-01-98-00400; 6/00)
• FDA Food Safety Inspection (OEI-05-90-01070; 8/91)

Back Top

Foster Care

• see also: Child Welfare
• In Five States, There Was No Evidence That Many Children in Foster Care Had a Screening for Sex Trafficking When They Returned After Going Missing OEI-07-19-00371
• Case Study: Missouri's Efforts To Protect Children Missing From Foster Care OEI-07-19-00372
• Treatment Planning and Medication Monitoring Were Lacking for Children in Foster Care Receiving Psychotropic Medication (OEI-07-15-00380)
• Not All Children in Foster Care Who Were Enrolled in Medicaid Received Required Health Screenings (OEI-07-13-00460)
• State Standards and Capacity to Track Frequency of Caseworker Visits With Children in Foster Care (OEI-04-03-00350; 01/06)
• State Standards and Practices for Content of Caseworker Visits With Children in Foster Care (OEI-04-03-00351; 01/06)
• Children's Use of Health Care Services While in Foster Care: Common Themes (OEI-07-00-00645; 07/05)
• Children's Use of Health Care Services While in Foster Care: New York (OEI-02-00-00362; 07/05)
• Children's Use of Health Care Services While in Foster Care: Georgia (OEI-07-00-00644; 02/05)
• Oversight of States? Subgrantee Monitoring in the Foster Care Program (OEI-05-03-00060; 01/05)
• States? Monitoring of Subgrantees in the Foster Care Program: A Description of Six States? Systems (OEI-05-03-00061; 01/05)
• Children?s Use of Health Care Services While in Foster Care: North Dakota (OEI-07-00-00643; 09/04)
• Foster Care Children's Use of Medicaid Services in Oregon (OEI-02-00-00363; 06/04)
• Children's Use of Health Care Services While in Foster Care: Illinois (OEI-07-00-00642)
• Children's Use of Health Care Services While in Foster Care: Texas (OEI-07-00-00641; 03/04)
• Children's Use of Health Care Services While in Foster Care: Kansas (OEI-07-00-00640; 08/03)
• Foster Care Children's Use of Medicaid Services in New Jersey (OEI-02-00-00360; 07/03)
• Retaining Foster Parents (OEI-07-00-00601)
• Recruiting Foster Parents (OEI-07-00-00600)
• Independent Living Program for Foster Care Youths: Strategies for Improved ACF Management and Program Reporting (OEI-01-93-00090; 11/94)
• Respite Care Services for Foster Parents (OEI-04-93-00070; 8/94)
• Respite Care Services for Foster Parents: Six Case Studies (OEI-04-93-00071; 8/94)
• Child Support for Children in State Foster Care (OEI-04-91-00980; 5/94)
• Incorrect Distribution of Child Support Collected on Behalf of Children in Non-IV-E Foster Care (OEI-04-91-00981; 5/94)
• Opportunities for ACF to Improve Child Welfare Services and Protections for Native American Children (OEI-01-93-00110; 8/94) Oversight of State Child Welfare Programs (OEI-01-92-00770; 6/94)
• Using Relatives for Foster Care (OEI-06-90-02390; 7/92)
• State Practices in Using Relatives for Foster Care (OEI-06-90-02391; 7/92)
• Child Support for IV-E Foster Care Children (OEI-04-91-00530; 5/92)
• Trends in Foster Care (OEI-01-90-00490; 1/92)
• Foster Care Administrative Costs (OAI-05-87-00012; 8/87)

Back Top

Fragmented Billing

• Liver Biopsies (OEI-12-88-00900; 9/92)
• Fragmented Physician Claims (OEI-12-88-00901; 9/92)

Back Top

Fraud

• see also: Eligibility
• 2020 Performance Data for the Senior Medicare Patrol Projects OEI-02-21-00180
• Medicare Advantage Organizations Are Missing Opportunities To Use Ordering Provider Identifiers To Protect Program Integrity OEI-03-19-00432
• Illinois Medicaid Fraud Control Unit: 2019 Onsite Review OEI-06-19-00510
• Montana Medicaid Fraud Control Unit: 2019 Onsite Inspection OEI-12-19-00170
• Questionable Billing for Compounded Topical Drugs in Medicare Part D (OEI-02-16-00440)
• Reliance on Unverified Patient Lists Creates a Vulnerability in Home Health Surveys (OEI-05-16-00510)
• Medicaid Fraud Control Units: Investigation and Prosecution of Fraud and Beneficiary Abuse in Medicaid Personal Care Services (OEI-12-16-00500)
• Kentucky State Medicaid Fraud Control Unit: 2017 Onsite Review (OEI-06-17-00030)
• Alaska State Medicaid Fraud Control Unit: 2016 Onsite Review (OEI-09-16-00430)
• Colorado State Medicaid Fraud Control Unit: 2016 Onsite Review (OEI 06-16-00520)
• Wisconsin State Medicaid Fraud Control Unit: 2016 Onsite Review (OEI-07-16-00240)
• Oregon State Medicaid Fraud Control Unit: 2016 Onsite Review (OEI-09-16-00200)
• Maryland State Medicaid Fraud Control Unit: 2016 Onsite Review (OEI-07-16-00140)
• North Carolina State Medicaid Fraud Control Unit: 2016 Onsite Review (OEI-07-16-00070)
• South Dakota State Medicaid Fraud Control Unit: 2016 Onsite Review (OEI-07-16-00170)
• Medicaid Fraud Control Units Fiscal Year 2015 Annual Report (OEI-07-16-00050)
• Virginia State Medicaid Fraud Control Unit: 2015 Onsite Review (OEI-07-15-00290)
• More Effort is Needed to Protect the Integrity of the Child Care and Development Fund Block Grant Program (OEI-03-16-00150)
• Massachusetts State Medicaid Fraud Control Unit: 2015 Onsite Review (OEI-07-15-00390)
• Pennsylvania State Medicaid Fraud Control Unit: 2015 Onsite Review (OEI 07-15-00360)
• Florida State Medicaid Fraud Control Unit: 2015 Onsite Review (OEI-07-15-00340)
• Medicaid: Vulnerabilities Related to Provider Enrollment and Ownership Disclosure (OEI-04-11-00590)
• Medicare: Vulnerabilities Related to Provider Enrollment and Ownership Disclosure (OEI-04-11-00591)
• Oklahoma State Medicaid Fraud Control Unit: 2014 Onsite Review (OEI-06-14-00630)
• California State Medicaid Fraud Control Unit: 2015 Onsite Review (OEI-09-15-00070)
• Delaware State Medicaid Fraud Control Unit: 2015 Onsite Review (OEI-07-15-00240)
• Georgia State Medicaid Fraud Control Unit: 2015 Onsite Review (OEI-07-15-00090)
• Inappropriate Payments and Questionable Billing for Medicare Part B Ambulance Transports (OEI-09-12-00351)
• Hawaii State Medicaid Fraud Control Unit: 2014 Onsite Review (OEI-09-14-00540)
• District of Columbia Medicaid Fraud Control Unit: 2015 Onsite Review (OEI-07-14-00660)
• Maine State Medicaid Fraud Control Unit: 2015 Onsite Review (OEI-07-15-00140)
• Questionable Billing for Medicare Ophthalmology Services (OEI-04-12-00280)
• Providers Terminated from One State Medicaid Program Continued Participating in Other States (OEI-06-12-00030)
• Questionable Billing for Medicaid Pediatric Dental Services in California (OEI-02-14-00480)
• Ohio State Medicaid Fraud Control Unit: 2014 Onsite Review (OEI-07-14-00290)
• Medicaid Fraud Control Units Fiscal Year 2014 Annual Report (OEI-06-15-00010)
• Alabama State Medicaid Fraud Control Unit: 2014 Onsite Review (OEI-06-13-00660)
• New Mexico State Medicaid Fraud Control Unit: 2014 Onsite Review  (OEI-09-14-00240)
• Iowa State Medicaid Fraud Control Unit: 2014 Onsite Review (OEI-06-14-00190)
• Questionable Billing for Medicaid Pediatric Dental Services in Indiana (OEI-02-14-00250)
• Connecticut State Medicaid Fraud Control Unit: 2013 Onsite Review (OEI-07-13-00540)
• Mississippi State Medicaid Fraud Control Unit: 2014 Onsite Review (OEI-09-13-00700)
• Indiana State Medicaid Fraud Control Unit: 2013 Onsite Review (OEI-07-13-00250)
• Utah State Medicaid Fraud Control Unit: 2013 Onsite Review (OEI-09-13-00490)
• Texas State Medicaid Fraud Control Unit: 2013 Onsite Review (OEI-06-13-00300)
• Questionable Billing for Medicare Electrodiagnostic Tests (OEI-04-12-00420)
• Minnesota State Medicaid Fraud Control Unit: 2013 Onsite Review (OEI-06-13-00200)
• Medicaid Fraud Control Units Fiscal Year 2013 Annual Report (OEI-06-13-00340)
• Less Than Half of Part D Sponsors Voluntarily Reported Data on Potential Fraud and Abuse (OEI-03-13-00030)
• Michigan State Medicaid Fraud Control Unit: 2013 Onsite Review (OEI-09-13-00070)
• Vermont Medicaid Fraud Control Unit: 2013 Onsite Review (OEI-02-13-00360)
• Not All Recommended Fraud Safeguards Have Been Implemented in Hospital EHR Technology (OEI-01-11-00570)
• Nevada State Medicaid Fraud Control Unit: 2012 Onsite Review (OEI-09-12-00450)
• Montana State Medicaid Fraud Control Unit: 2012 Onsite Review (OEI-09-12-00700)
• Questionable Billing for Polysomnography Services (OEI-05-12-00340)
• Arkansas State Medicaid Fraud Control Unit: 2013 Onsite Review (OEI-06-12-00720)
• New Jersey Medicaid Fraud Control Unit: 2013 Onsite Review (OEI-02-13-00020)
• Medicare Inappropriately Paid for Drugs Ordered by Individuals Without Prescribing Authority (OEI-02-09-00608)
• Prescribers With Questionable Patterns in Medicare Part D (OEI-02-09-00603)
• Illinois State Medicaid Fraud Control Unit: 2012 Onsite Review (OEI-07-12-00510)
• Tennessee State Medicaid Fraud Control Unit: 2012 Onsite Review (OEI-06-12-00370)
• Idaho State Medicaid Fraud Control Unit: 2012 Onsite Review (OEI-09-12-00220)
• Louisiana State Medicaid Fraud Control Unit: 2012 Onsite Review (OEI-09-12-00010)
• New Hampshire Medicaid Fraud Control Unit: 2012 Onsite Review (OEI-02-12-00180)
• South Carolina State Medicaid Fraud Control Unit: 2011 Onsite Review (OEI-09-11-00610)
• CMS Response to Breaches and Medical Identity Theft (OEI-02-10-00040)
• Surety Bonds Remain an Unused Tool to Protect Medicare from Home Health Overpayments (OEI-03-12-00070)
• Kansas State Medicaid Fraud Control Unit: 2012 Onsite Review (OEI-07-12-00200)
• New York State Medicaid Fraud Control Unit: 2011 Onsite Review (OEI-02-11-00440)
• Louisiana Medicaid Payments and Services Related to Hurricanes Katrina and Rita: Data Compendium (OEI-05-07-00300)
• Retail Pharmacies With Questionable Part D Billing (OEI-02-09-00600)
• Status of 244 Provider Audits Identified Using Review Medicaid Integrity Contractor Analysis (OEI-05-10-00201)
• Medicare Advantage Organizations' Identification of Potential Fraud and Abuse (OEI-03-10-00310)
• Early Assessment of Review Medicaid Integrity Contractors (OEI-05-10-00200)
• Medicaid Managed Care: Fraud and Abuse Concerns Remain Despite Safeguards (OEI-01-09-00550)
• South Florida Medicare Comprehensive Outpatient Rehabilitation Facilities (OEI 05 10-00090)
• Zone Program Integrity Contractors' Data Issues Hinder Effective Oversight (OEI-03-09-00520)
• Use of Surety Bonds to Recover Overpayments Made to Suppliers of Durable Medical Equipment, Prosthetics, Orthotics, and Supplies: Early Findings (OEI-03-11-00351)
• Medicare Prescription Drug Sponsors' Training To Prevent Fraud, Waste, and Abuse (OEI-01-10-00060)
• Questionable Billing for Brand-Name Inhalation Drugs in South Florida (OEI-03-09-00530)
• Medicare and Medicaid Fraud and Abuse Training in Medical Education (OEI-01-10-00140)
• Recovery Audit Contractors? Fraud Referrals (OEI-03-09-00130)
• CMS?s Implementation of Safeguards During Fiscal Year 2006 to Prevent and Detect Fraud and Abuse in Medicare Prescription Drug Plans (OEI-06-06-00280)
• Medicare?s Program Safeguard Contractors: Activities To Detect and Deter Fraud and Abuse (OEI-03-06-00010)
• Suspected Medicaid Fraud Referrals (OEI-07-04-00181; 01/07)
• Medicare?s Program Safeguard Contractors: Performance Evaluation Reports (OEI-03-04-00050; 03/06)
• Beneficiary Awareness of Medicare Fraud: A Follow-up (OEI-09-00-00590; 11/01)
• Performance Data for the Senior Medicare Patrol Projects: August 2001 Performance Report (OEI-02-01-00301)
• Performance Data for the Senior Medicare Patrol Projects: March 2001 Report (OEI-02-01-00300; 03/01)
• Three Year Performance Data for the HIPAA-Funded Projects (OEI-02-97-00528; 10/00)
• Three Year and One Year Performance Data for the Senior Medicare Patrol Projects (OEI-02-97-00527; 9/00)
• Birth Certificate Fraud (OEI-07-99-00570; 9/00)
• 24-Month Performance Data for the HIPAA-Funded Project Grantees (OEI-02-97-00524; 12/99)
• 24-Month Performance Data for Senior Medicare Patrol Projects (OEI-02-97-00523; 9/99)
• The Administration on Aging's Health Care Fraud and Abuse Programs: 18-Month Outcomes (OEI-02-99-00110; 8/99)
• Implementation of the Administration on Aging's Health Care Fraud and Abuse Programs (OEI- 02-99-00111; 8/99)
• Medicaid Managed Care Fraud and Abuse (OEI-07-96-00250; 6/99)
• Health Care Anti-Fraud, Waste, and Abuse Community Volunteer Program -- First Year Outcomes (OEI-02-97-00522; 3/99)
• Fiscal Intermediary Fraud Units (OEI-03-97-350; 11/98)
• Health Care Anti-Fraud Volunteer Project Performance Measures (OEI-02-97-00520; 4/98)
• Beneficiary Awareness of Medicare Fraud (OEI-12-97-00440; 1/98)
• Carrier Fraud Units (OEI-05-94-00470; 11/96)
• Surveillance and Utilization Review Subsystem Referrals (OEI-07-95-00030; 11/96)
• AFDC Pre-Eligibility Fraud Investigative Units (OEI-04-91-00101; 3/95)
• Referrals by Medicaid Agencies to Fraud Control Units (OAI-03-88-00170; 10/89)
• Oversight of State Medicaid Fraud Control Units (OAI-01-87-00015; 8/88)
• State Investigation of Fraud in the AFDC Program (OAI-04-86-00066; 12/87)

Back Top

Funding

• HHS's Suspension and Debarment Program Helped Safeguard Federal Funding, But Opportunities for Improvement Exist OEI-04-19-00570
• Federal Approaches to Funding Public Health Programs (OEI-01-94-00160; 7/95)